{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:42:51Z","timestamp":1761489771772,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"PML Consortium (RPV)","award":["114244"],"award-info":[{"award-number":["114244"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UO1-AI-35042","5-MO1-RR-00052 (GCRC)","UO1-AI-35043","UO1-AI-35039","UO1-AI-35040","UO1-AI-35041"],"award-info":[{"award-number":["UO1-AI-35042","5-MO1-RR-00052 (GCRC)","UO1-AI-35043","UO1-AI-35039","UO1-AI-35040","UO1-AI-35041"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.virol.2015.08.022","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T08:15:12Z","timestamp":1441613712000},"page":"467-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients"],"prefix":"10.1016","volume":"485","author":[{"given":"Francesca","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Palella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Margolick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Viscidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2015.08.022_bib1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.micinf.2012.02.002","article-title":"BK polyomavirus: emerging pathogen","volume":"14","author":"Bennett","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.virol.2015.08.022_bib2","unstructured":"Biogen Idec, 2015. Biogen Idec website. Ref Type: Online Source."},{"key":"10.1016\/j.virol.2015.08.022_bib3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2015.08.022_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneurol.2010.164","article-title":"Progressive multifocal leukoencephalopathy and other forms of JC virus disease","volume":"6","author":"Brew","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.virol.2015.08.022_bib5","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.4049\/jimmunol.153.5.2064","article-title":"Immunization of BALB\/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity","volume":"153","author":"Bright","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2015.08.022_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1681\/ASN.2010080877","article-title":"Inhibitory interactions between BK and JC virus among kidney transplant recipients","volume":"22","author":"Cheng","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.virol.2015.08.022_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000311014","article-title":"Progressive multifocal leukoencephalopathy deaths in the USA, 1979\u20132005","volume":"35","author":"Christensen","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.virol.2015.08.022_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1473-3099(09)70226-9","article-title":"Progressive multifocal leukoencephalopathy in HIV-1 infection","volume":"9","author":"Cinque","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2015.08.022_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.puhe.2011.11.013","article-title":"The multicenter AIDS Cohort Study, 1983 to \u2026","volume":"126","author":"Detels","year":"2012","journal-title":"Public Health"},{"key":"10.1016\/j.virol.2015.08.022_bib10","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/brain\/awh215","article-title":"A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy","volume":"127","author":"Du Pasquier","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.virol.2015.08.022_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.08.022_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC virus antibodies: implications for PML risk stratification","volume":"68","author":"Gorelik","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.virol.2015.08.022_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/JCM.38.1.105-109.2000","article-title":"Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus","volume":"38","author":"Hamilton","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2015.08.022_bib14","doi-asserted-by":"crossref","first-page":"e1000363","DOI":"10.1371\/journal.ppat.1000363","article-title":"Seroepidemiology of human polyomaviruses","volume":"5","author":"Kean","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2015.08.022_bib15","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/JVI.02657-08","article-title":"JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy","volume":"83","author":"Khanna","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.08.022_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2015.08.022_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/PPA.S20791","article-title":"An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations","volume":"9","author":"Kornek","year":"2015","journal-title":"Patient Preference Adherence"},{"key":"10.1016\/j.virol.2015.08.022_bib18","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1099\/vir.0.82094-0","article-title":"T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus","volume":"87","author":"Li","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.08.022_bib19","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1128\/JVI.01189-13","article-title":"BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism","volume":"87","author":"Pastrana","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.08.022_bib20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Plavina","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.virol.2015.08.022_bib21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/ki.2014.38","article-title":"JC polyoma virus and kidney disease","volume":"85","author":"Rossi","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.virol.2015.08.022_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mcp.2014.11.007","article-title":"Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients","volume":"29","author":"Rossi","year":"2015","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.virol.2015.08.022_bib23","series-title":"Infectious Diseases","first-page":"1570","article-title":"Polyomaviurses","author":"Viscidi","year":"2010"},{"key":"10.1016\/j.virol.2015.08.022_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/0-387-32957-9_5","article-title":"Serological cross reactivity between polyomavirus capsids","volume":"577","author":"Viscidi","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virol.2015.08.022_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/cir507","article-title":"JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals","volume":"53","author":"Viscidi","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2015.08.022_bib26","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/CVI.05175-11","article-title":"Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus","volume":"18","author":"Viscidi","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.virol.2015.08.022_bib27","first-page":"278","article-title":"Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays","volume":"10","author":"Viscidi","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215003797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215003797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:35:22Z","timestamp":1758587722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682215003797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"alternative-id":["S0042682215003797"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2015.08.022","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2015.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}